Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
6 June 2022 |
Main ID: |
NCT02786615 |
Date of registration:
|
26/05/2016 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Increasing MSM in the Continuum of Care in Kazakhstan
|
Scientific title:
|
Increasing Involvement of MSM in the Continuum of Care in Kazakhstan |
Date of first enrolment:
|
June 27, 2018 |
Target sample size:
|
987 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02786615 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Kazakhstan
|
United States
| | | | | | |
Contacts
|
Name:
|
Elwin Wu, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Columbia University |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- be at least 18 years old;
- identify as male; and
- report oral or anal intercourse with another man in the past 12 months; and
- report binge alcohol consumption and/or illicit use of substances in the past 12
months
Exclusion Criteria:
- has a language or cognitive impairment that would prevent comprehension of study
procedures, risks, and benefits (described in Russian during the informed consent
process)
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
HIV
|
Substance-Related Disorders
|
Intervention(s)
|
Behavioral: Peer Unity
|
Primary Outcome(s)
|
Engagement in the HIV care continuum: HIV testing
[Time Frame: Past 6 months]
|
Secondary Outcome(s)
|
For PLWH, engagement in the HIV care continuum related to HIV medical treatment
[Time Frame: Since confirmed HIV infection diagnosis]
|
Secondary ID(s)
|
1R01DA040513-01A1
|
AAAQ7251
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|